MARKET

MOLN

MOLN

MOLECULAR PARTNERS AG
NASDAQ
5.08
-0.14
-2.68%
Closed 16:00 12/20 EST
OPEN
5.19
PREV CLOSE
5.22
HIGH
5.19
LOW
5.06
VOLUME
14.99K
TURNOVER
--
52 WEEK HIGH
12.70
52 WEEK LOW
3.320
MARKET CAP
204.85M
P/E (TTM)
-3.9799
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MOLN last week (1209-1213)?
Weekly Report · 12/16 09:12
Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet
NASDAQ · 12/13 14:55
Weekly Report: what happened at MOLN last week (1202-1206)?
Weekly Report · 12/09 09:12
Reported Sunday, Molecular Partners Reports Initial Efficacy And Safety Data For MP0533 In Phase 1/2a Study And Preclinical Success Of MP0621 At ASH 2024
Benzinga · 12/09 08:12
Molecular Partners AG Reports Acceptable Safety Profile and Initial Efficacy Data for MP0533 and MP0621 at ASH 2024
Barchart · 12/08 21:22
Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024
Barchart · 12/08 11:00
Weekly Report: what happened at MOLN last week (1125-1129)?
Weekly Report · 12/02 09:12
Weekly Report: what happened at MOLN last week (1118-1122)?
Weekly Report · 11/25 09:11
More
About MOLN
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.

Webull offers Molecular Partners AG (ADR) stock information, including NASDAQ: MOLN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MOLN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MOLN stock methods without spending real money on the virtual paper trading platform.